BSECompany Update5 Nov 2026 · 5 Nov 2026, 09:31 pm
Wholly Owned Subsidiary of the Company namely 'Eiko Scientific Solutions LLP' (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited. The private limited company will be incorporated as a joint venture between Oval Projects Engineering Limited and Eiko Scientific Solutions LLP, with each holding 50% of share capital.
Eiko Lifesciences Ltd · 540204
✦ AI SummaryJoint Venture
Eiko Lifesciences Ltd's wholly owned subsidiary, Eiko Scientific Solutions LLP, is proposed to enter into a joint venture with Oval Projects Engineering Limited to form a new private limited company, Oval Eiko Resources Private Limited, with each holding 50% of the share capital.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Eiko Lifesciences Ltd - 540204 - Announcement under Regulation 30 (LODR)-Restructuring
Attachments (1)
📄pdf
Download →
ae07889c-9035-4846-b76a-5c2f97c98de8.pdf
View document text
Date: 05th November, 2026
Corporate Services Department
BSE Limited
Phiroze Jeejeebhoy Towers,
1st Floor, Dalal Street,
Fort, Mumbai – 400001
Scrip Code: 540204
Subject: Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015 - Proposed
Incorporation of a Private Limited Company by way of Joint Venture by Wholly Owned Subsidiary
Dear Sir/ Madam,
We wish to inform that the Wholly Owned Subsidiary of the Company namely “Eiko Scientific Solutions
LLP” (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects
Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources
Private Limited.
The private limited company will be incorporated as a joint venture between Oval Projects Engineering
Limited and Eiko Scientific Solutions LLP, with each holding 50% of share capital.
Disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 and other applicable circulars,
if any, is enclosed herewith as “Annexure A”.
Kindly take the above on record and oblige.
For Eiko LifeSciences Limited
Chintan Doshi
Company Secretary and Compliance Officer
Membership No: ACS 36190
Encl. As Above
Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134
Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604
Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com
Annexure – A
Acquisition of ‘to be incorporated’ companies:
Particular Details
Name of the entity, date & country of Name: Oval Eiko Resources Private Limited
incorporation, etc.
Date: Name Approval from MCA received on
23/10/2026
Country of Incorporation: India
Name of holding company of the Eiko Scientific Solutions LLP shall be holding
incorporated company and relation with the 50% of the Share Capital in the Proposed
listed entity Company (to be formed as a 50-50 Joint
Venture Between Eiko Scientific Solutions
LLP and Oval Projects Engineering Limited)
Eiko Scientific Solutions LLP is wholly owned
Subsidiary of the Listed Entity.
Industry to which the entity being Renewable Energy: Compressed Bio Gas
incorporated belongs Production and Distribution
Brief background about the entity Oval Eiko Resources Private Limited will be
incorporated in terms of products / line of into Renewable Energy and Compressed Bio
business Gas Production and Distribution.
Broad Business Activities : Renewable
Energy: Compressed Bio Gas, Condensation
stabilization Unit or Industrial Fuel and
chemical unit, Essential oil Unit, Engineered
wood unit, etc.
Brief details of any government or Regulatory NA
approval required for the acquisition.
Nature of consideration - whether cash Cash Consideration
consideration or share swap and details of
the same;
Cost of subscription / price at which the Rs. 2,50,000/- (initial proposed Capital)
shares are subscribed
Eiko Scientific Solutions LLP will subscribe
50% of the Total Share Capital i.e. 25000
Equity Shares of Rs. 10 each.
percentage of shareholding / control by the Eiko Scientific Solutions LLP is wholly owned
listed entity and / or number of shares Subsidiary of Eiko Lifesciences Ltd. (Listed
allotted Entity). 99.99 % Shares are held by the Listed
Entity and 0.01% Shares are held by Nominee
of the Listed Entity.
Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134
Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604
Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com